Home › Asset managers › Compare 2024-2025 › Lincoln Financial vs Northern Trust
Lincoln Financial 2024-2025 · Northern Trust 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 69,170 | 60,135 | 3,348 | 5,687 | 94.7% | 91.7% |
| Board proposals | 56,126 | 48,241 | 3,034 | 4,851 | 94.1% | 91.0% |
| E&S shareholder proposals | 256 | 89 | 19 | 148 | 82.4% | 64.1% |
| Other items | 12,788 | 11,805 | 295 | 688 | 97.6% | 95.6% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
9,035 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Lincoln Financial | Northern Trust |
|---|---|---|---|---|---|---|
| CREATE RESTAURANTS HOLDINGS INC. | May 28, 2025 | Elect Director Goto, Hitoshi Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREATE RESTAURANTS HOLDINGS INC. | May 28, 2025 | Elect Director Kawai, Jun Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREATE SD HOLDINGS CO. LTD. | August 23, 2024 | Elect Director Hirose, Taizo Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREATE SD HOLDINGS CO. LTD. | August 23, 2024 | Elect Director Yamamoto, Hisao Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Russell Freeman Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.c Re-election of Maria Fardis, Ph.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.d Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.e Re-election of Simeon J. George, M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.f Re-election of John T. Greene Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.g Re-election of Katherine A. High, M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.h Re-election of Sandesh Mahatme, LL.M. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.i Re-election of Christian Rommel, Ph.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.j Re-election of Douglas A. Treco, Ph.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 4.k Election of Briggs W. Morrison, M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 5.b Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 5.c Re-election of John T. Greene Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 5.d Election of Briggs W. Morrison, M.D. Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CROSS COUNTRY HEALTHCARE INC. | February 28, 2025 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Cross Country's named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 5 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Ramkumar Mandalam, PhD Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| CRYSTAL INTERNATIONAL GROUP LTD. | May 30, 2025 | Elect Lo Lok Fung Kenneth as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CSPC PHARMACEUTICAL GROUP LTD. | May 30, 2025 | Elect Wang Bo as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Elect SHENG-YUNG YANG, with Shareholder No. 1018764, as Independent Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Andrew W. Hobson Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Brian G. Kushner Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Deborah A. Farrington Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Joan Hogan Gillman Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Mary G. Berner Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Election of Directors: Thomas H. Castro Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CUMULUS MEDIA INC. | May 30, 2025 | Proposal to approve, on an advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CUSTOM TRU | June 12, 2025 | To elect each of the four Class C directors to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified: Fred Ross Director Elections |
Board | Not determined | WITHHOLD 2 funds |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Elect Rolly van Rappard as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVS GROUP PLC | November 20, 2024 | Re-elect Richard Gray as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CYBERAGENT INC. | December 13, 2024 | Elect Director Fujita, Susumu Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Central New Energy Holding Group Limited | June 27, 2025 | Elect Yu Zhuyun as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Central New Energy Holding Group Limited | June 27, 2025 | Elect Zhu Yujuan as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | FOR 1 fund |
AGAINST 3 funds |
| DAH SING BANKING GROUP LTD. | May 30, 2025 | Elect Robert Tsai-To Sze as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DAICEL CORP. | June 20, 2025 | Elect Director Ogawa, Yoshimi Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DAICEL CORP. | June 20, 2025 | Elect Director Sakaki, Yasuhiro Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DAIHEN CORP. | June 26, 2025 | Elect Director Minomo, Shoichiro Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DAIHEN CORP. | June 26, 2025 | Elect Director Tajiri, Tetsuya Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DAIO PAPER CORP. | June 26, 2025 | Elect Director Wakabayashi, Yorifusa Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DAISEKI CO. LTD. | May 22, 2025 | Elect Director Yamamoto, Tetsuya Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Gerald Aberle Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| DAKOTA GOLD CORP. | May 13, 2025 | Election of Directors: Stephen O'Rourke Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DANIELI & C. OFFICINE MECCANICHE SPA | October 25, 2024 | Approve Second Section of the Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | December 31, 2024 | Approve Financing Proposal of Datang International as the Parent Company for the Year of 2025 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DATANG INTERNATIONAL POWER GENERATION CO. LTD. | March 25, 2025 | Approve Centralized Registration of Non-Financial Corporate Debt Financing Instruments and Shelf Offering of Corporate Bonds Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Fabio Di Fede as Executive Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Paolo Marchesini as Executive Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| DAVIDE CAMPARI-MILANO NV | April 16, 2025 | Reelect Robert Kunze-Concewitz as Non-Executive Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| DCM HOLDINGS CO. LTD. | May 29, 2025 | Elect Director Hisada, Toshihiro Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DCM HOLDINGS CO. LTD. | May 29, 2025 | Elect Director Ishiguro, Yasunori Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DELEK AUTOMOTIVE SYSTEMS LTD. | July 8, 2024 | Approve Amended Compensation Policy for the Directors and Officers of the Company Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DELIVERY HERO SE | June 18, 2025 | Approve Creation of EUR 14.7 Million Pool of Authorized Capital 2025/II with or without Exclusion of Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DELIVERY HERO SE | June 18, 2025 | Approve Creation of EUR 14.7 Million Pool of Authorized Capital 2025/III with or without Exclusion of Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| DELTA GALIL INDUSTRIES LTD. | July 23, 2024 | Reelect Tzipora Carmon as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DENALI THERAPEUTICS INC. | June 3, 2025 | ELECTION OF DIRECTORS: Julian Baker Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 2 funds |
| DENKA CO. LTD. | June 20, 2025 | Elect Director Imai, Toshio Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DENKA CO. LTD. | June 20, 2025 | Elect Director Ishida, Ikuo Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| DENTSU GROUP INC. | March 28, 2025 | Elect Director Igarashi, Hiroshi Director Elections |
Board | For | FOR 2 funds |
AGAINST 6 funds |
← Previous Page 11 of 91 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.